文献速递胃肠外科围术期管理与 ERAS

择期结直肠癌手术中消化道选择性去污染的随机临床试验(SELECT试验)

Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
PubMed 文献 · Br J Surg · 2019-02-25

这项在荷兰六中心开展的多中心开放标签随机对照试验,评估口服多粘菌素E、妥布霉素和两性霉素B行消化道选择性去污染(SDD)能否减少择期结直肠癌手术并发症。

要点

  • SDD可降低择期结直肠癌切除术后感染性并发症发生率。
  • SDD未显著降低吻合口漏发生率。
  • 两组均接受头孢唑林联合甲硝唑围术期预防。

核心结论

  • SDD减少结直肠癌切除术后感染性并发症,但未显著减少吻合口漏。

研究设计与样本

  • 荷兰六中心多中心开放标签随机对照试验,纳入择期根治性手术并一期吻合的结直肠癌患者。
  • SDD组228例与对照组227例纳入分析,因中期分析显示优效性不可达成而提前终止。

主要发现

  • 直肠拭子间隔DNA谱分析证实SDD有效。

临床怎么用

  • 对择期结直肠癌手术患者,可考虑围术期口服SDD以降低感染性并发症。
  • 不应将SDD视为降低吻合口漏的确定性措施。

局限性

  • 试验因中期分析显示优效性不可达成而提前终止。
  • 开放标签设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infectious complications and anastomotic leakage affect approximately 30 per cent of patients after colorectal cancer surgery. The aim of this multicentre randomized trial was to investigate whether selective decontamination of the digestive tract (SDD) reduces these complications of elective colorectal cancer surgery. METHODS: The effectiveness of SDD was evaluated in a multicentre, open-label RCT in six centres in the Netherlands. Patients with colorectal cancer scheduled for elective curative surgery with a primary anastomosis were eligible. Oral colistin, tobramycin and amphotericin B were administered to patients in the SDD group to decontaminate the digestive tract. Both treatment and control group received intravenous cefazolin and metronidazole for perioperative prophylaxis. Mechanical bowel preparation was given for left-sided colectomies, sigmoid and anterior resections. Anastomotic leakage was the primary outcome; infectious complications and mortality were secondary outcomes. RESULTS: The outcomes for 228 patients randomized to the SDD group and 227 randomized to the control group were analysed. The trial was stopped after interim analysis demonstrated that superiority was no longer attainable. Effective SDD was confirmed by interspace DNA profiling analysis of rectal swabs. Anastomotic leakage was observed in 14 patients (6·1 per cent) in the SDD group and in 22 patients (9·7 per cent) in the control group (odds ratio (OR) 0·61, 95 per cent c.i. 0·30 to 1·22). Fewer patients in the SDD group had one or more infectious complications than patients in the control group (14·9 versus 26·9 per cent respectively; OR 0·48, 0·30 to 0·76). Multivariable analysis indicated that SDD reduced the rate of infectious complications (OR 0·47, 0·29 to 0·76). CONCLUSION: SDD reduces infectious complications after colorectal cancer resection but did not significantly reduce anastomotic leakage in this trial. Registration number: NCT01740947 ( https://www.clinicaltrials.gov).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Abis GSA, Stockmann HBAC, Bonjer HJ, et al. Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial). Br J Surg. 2019. PMID: 30802304. doi:10.1002/bjs.11117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。